advertisement

Watch: Bharat Biotech's Covaxin shows 77.8% efficacy in Phase 3 trial

India Today Television
New Delhi,UPDATED: Jul 3, 2021 23:32 IST

Bharat Biotech on Saturday announced the efficacy analysis data from Phase 3 clinical trials of its Covid vaccine Covaxin. The vaccine has been found to be 77.8 per cent effective.

Read more!
More videos from Coronavirus Outbreak

VIDEOS FROM OTHER SECTIONS

ProgrammeIndia First

LATEST VIDEOS

advertisement
advertisement